Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

We recently published a list of the 10 Best Soaps and Cleaning Materials Stocks to Invest In. In this article, we are going ...

Johnson & Johnson said Monday it expects to accelerate sales growth beyond Wall Street expectations in the field of ...

Johnson & Johnson “should have known that the J&J Products contained harmful, deleterious, carcinogenic and inherently dangerous asbestos dust and fibers” and the products reportedly did not ...

Johnson & Johnson is a holding company ... and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines ...

Her diagnosis was "a direct and proximate result of Ms Cartwright's inhalation and ingestion of asbestos contained within the J&J products," it alleged. Johnson & Johnson has denied the ...

In 2021, Johnson & Johnson unveiled a plan to spin off its consumer products division to focus on pharmaceuticals and medical technology. The company completed the Kenvue spinoff to shareholders ...